Solutions to drive clinical efficiency for complex PCI challenges
Need more information on complex PCI?
Need more information on complex PCI?
Defining complex PCI characteristics
Complex PCI cases are increasingly more common, leading to an increased risk of adverse events. Certain lesion characteristics present common technical difficulties regardless of the lesion’s anatomic location or type. Complex PCI cases have defining characteristics such as restenosis, severe calcification, extensive thrombotic burden, extreme tortuosity and chronic total occlusion. Philips coronary portfolio provides comprehensive imaging and therapy tools to clearly assess complex clinical scenarios to treat patients. Clear procedural guidance and optimal vessel preparation can help you achieve better patient outcomes. Explore the different challenges seen in complex PCI cases and how Philips’ specialty tools can help.
Learn more about ultra-low contrast PCI here.
Resistant or restenotic lesions
Resistant and restenotic lesions exhibit characteristics making them challenging to dilate and treat with conventional tools. Learn more about how our products, ELCA coronary laser atherectomy catheter, AngioSculpt Evo Rx PTCA scoring balloon catheter and IVUS imaging help you achieve optimal results in your treatment decisions.
Anatomically complex lesions
Anatomically complex lesions exhibit challenging characteristics complicating visualization, crossing and treatment planning. Learn the challenges of treating anatomically complex lesions and how our products ELCA coronary laser atherectomy, AngioSculpt Evo Rx PTCA scoring balloon catheter and IVUS imaging may assist in treatment.
Advanced physiologic guidance, imaging and vessel prep for PCI planning
Multiple modalities (iFR, FFR, IVUS) on a single platform.
Multiple modalities (iFR, FFR, IVUS) on a single platform.
Provides area/diameter measurements for accurate stent sizing.
Solid core workhorse design for flexibility.
Highly deliverable scoring balloon, with the power to safely dilate resistant lesions.1,2,3
Indicated for occluded saphenous vein, ostial lesions, moderately calcified stenosis, total occlusions, and more.
Plan, land and expand stents optimally
Learn how Dr. Kerrigan defines stent optimization
Enable improved outcomes and fewer complications. The treatment of coronary lesions with DES is complicated by the challenges of suboptimal post stent results, such as stent under expansion, incomplete stent apposition, edge dissection and geographic miss, which may contribute to increased risk of stent failure.
Maximize gain. Minimize risk.
Maximize luminal gain with Philips’ most deliverable specialty balloon1 redesigned from tip to tail for superior deliverability.
When selecting a balloon for complex PCI cases, deliverability, crossability, and dilatation power are key factors. The Philips Scoring Balloon Catheter – AngioSculpt Evo – is designed for exceptional performance in all three factors. Experience the combined power, safety and deliverability that AngioSculpt Evo provides during your next treatment plan.
Explore the new features of AngioSculpt Evo below:
Super deliverability, controlled power and a strong safety profile
-
-
AngioSculpt Evo provides improved lesion entry compared to previous-generation models.5 Designed to improve wire trackability, lesion entry, and crossability with a shorter more lubricous tip to decrease friction and facilitate lesion entry.
• 12% reduction in tip diameter
• 26% reduction in tip length
• Tip infused with barium sulphate for added lubricity
• 38% less advancement force
You are about to visit a Philips global content page
Continue -
Nitinol scoring elements help minimize slippage as they are wrapped around the entire balloon to concentrate focal forces and lock itself to the lesion to crack calcium. AngioSculpt Evo provides you the controlled power you need to achieve more luminal gain.
You are about to visit a Philips global content page
Continue -
AngioSculpt Evo reduces push force by 38% compared to our previous generation AngioSculpt with its new hydrophilic coating, which reduces friction for greater crossability.4 AngioSculpt Evo is 44% more deliverable than the Wolverine balloon and 37% more deliverable than the current AngioSculpt PTCA.5
You are about to visit a Philips global content page
Continue -
Improved catheter joint design for tortuous anatomy and is 5F guide compatible. 83% of physicians rated AngioSculpt Evo as deliverable as, or more deliverable than, a non-compliant balloon.6
You are about to visit a Philips global content page
Continue -
Laser-cut hypotube increases flexibility while still maintaining column strength in the aortic arch for controlled power and deliverability in tortuous anatomy.
You are about to visit a Philips global content page
Continue
Combine the power of our therapeutics for optimal vessel preparation
Successful coronary stent placement and treatment in complex cases needs proper vessel preparation. However, traditional balloon angioplasty may lead to unpredictable results and has a high rate of uncontrolled dissections. By combining the power of our Philips Coronary Laser Atherectomy System and Catheter and our AngioSculpt Evo Scoring Balloon, you can efficiently and effectively prepare vessels for optimal stent placement within a variety of lesion morphologies or case complexities. Our coronary laser atherectomy solutions and scoring balloon result in:
Efficiency
Plaque that is modified for optimal stent delivery, expansion and apposition.
Flexibility
Treat a wide variety of lesion complexities, types and morphologies.
Outcomes
Properly modified plaque leads to better stent delivery, expansion and apposition, increasing the chances of better long-term outcomes.
See how our laser atherectomy solutions and scoring balloon can help in your next complex PCI case:
Physician and product videos
Enable improved outcomes and fewer complications. The treatment of coronary lesions with DES is complicated by the challenges of suboptimal post stent results, such as stent under expansion, incomplete stent apposition, edge dissection and geographic miss, which may contribute to increased risk of stent failure.
Use of iFR and IVUS Co-Registration to simplify PCI decision-making
How does laser atherectomy actually work?
New AngioSculpt Evo - see the power and safety of a scoring balloon
IVUS apps designed for interventional cardiologists
Check out the IVUS App for interactive workflow and image interpretation practice
Learn IVUS virtually with the Cardio Ex app
Philips ELIITE Academy is focused on delivering high value and real-time strategic educational programs that meet the evolving needs of our customers.
To initiate your clinical pathway or register for one our cardiovascular US medical educational programs, please contact your local Philips representative.
For more information on the available courses, please visit www.igtdacademy.philips.com.
ELCA important safety information indications:
The laser catheters are intended for use either as a stand-alone modality or in conjunction with percutaneous transluminal coronary balloon angioplasty (PTCA) in patients who are acceptable candidates for coronary artery bypass graft (CABG) surgery. The following indications for use, contraindications and warnings have been established through multicenter clinical trials. The Philips CVX-300 Excimer laser system and the multi-fiber laser catheter models are safe and effective for the following indications: occluded saphenous vein bypass grafts, ostial lesions, long lesions (greater than 20mm in length), moderately calcified stenosis, total occlusions traversable by a guidewire, lesions which previously failed balloon angioplasty, restenosis in 316L stainless steel stents, prior to the administration of intravascular brachytherapy. These lesions must be traversable by a guidewire and composed of atherosclerotic plaque and/or calcified material. The lesions should be well defined by angiography. Contraindications: Lesion is in an unprotected left main artery. Lesion is beyond acute bends or is in a location within the coronary anatomy where the catheter cannot traverse. Guidewire cannot be passed through the lesion. Lesion is located within a bifurcation. Patient is not an acceptable candidate for bypass graft surgery. Potential adverse events: Use of the Philips CVX-300 Excimer laser system may contribute to the following complications: dissection of the arterial wall, perforation, acute reclosure, embolization, aneurysm formation, spasm, coronary artery bypass graft surgery, thrombus, myocardial infarction, arrhythmia, filling defects, death. No long term adverse effects of ELCA are known at this time. Risks: The primary endpoint defined in the laser angioplasty of restenosis stents (LARS) randomized trial was the absence of major adverse cardiac events (MACE) at 6 months: Death; myocardial infarction; coronary artery bypass surgery. Procedural complications include: any dissection, acute thrombus, haziness, no reflow, arrhythmia, acute vessel closure, occlusion of side branch, occlusion non-target, coronary spasm, coronary embolism, coronary perforation, laser/stent damage, balloon/stent damage,
and other serious. Caution: Federal law restricts this device to sale by or on the order of a physician.
Summary of safety and effectiveness – PTCA catheter AngioSculpt Evo PTCA important safety information
The AngioSculpt Evo scoring balloon catheter is indicated for use in the treatment of hemodynamically significant coronary artery stenosis, including in-stent restenosis and
complex type C lesions, for the purpose of improving myocardial perfusion.
The AngioSculpt Evo catheter should not be used for coronary artery lesions unsuitable for treatment by percutaneous revascularization, and coronary artery spasm in the absence of a significant stenosis.
Possible adverse effects include, but are not limited to: death; heart attack (acute myocardial infarction); embolism, total occlusion of the treated coronary artery; coronary artery dissection, perforation, rupture, or injury; pericardial tamponade; no/slow reflow of treated vessel; emergency coronary artery bypass (CABG); emergency percutaneous coronary intervention; CVA/stroke/ embolic stroke; pseudoaneurysm; restenosis of the dilated vessel; unstable angina; thromboembolism or retained device components; irregular heart rhythm (arrhythmias, including life-threatening ventricular arrhythmias); severe low (hypotension)/high (hypertension) blood pressure; coronary artery spasm; hemorrhage or hematoma; need for blood transfusion; surgical repair of vascular access site; creation of a pathway for blood flow between the artery and the vein in the groin (arteriovenous fistula); drug reactions, allergic reactions to x-ray dye (contrast medium); and infection. This information is not intended to replace a discussion with your healthcare provider on the benefits and risks of this procedure to you.
Caution:
Federal law restricts this device to sale by or on the order of a physician.
